Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MIST RCT
NCT04590404Phase 3Completed
- Sponsor
- Vanderbilt-Ingram Cancer Center
- Start
- Nov 2020
- Primary completion
- May 2024
- Modality
- Transdermal Patches, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of varenicline, nicotine patch in Tobacco Use Disorder (TUD), sponsored by Vanderbilt-Ingram Cancer Center. Started Nov 2020; status: completed.
02
Drugs
vareniclinenicotine patch
03
Conditions
Tobacco Use Disorder (TUD)
Beyond the preview
Go deeper on NCT04590404.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04590404.